Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | XDH | P47989 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2298745 | 0.98 | ATM (0.74) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL431955 | 0.92 | ATM (0.67) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL30067639 | 0.92 | ATM (0.67) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL56952 | 0.92 | ATM (0.67) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL4099107 | 0.90 | ATM (0.65) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL8098340 | 0.90 | ATM (0.65) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| Benzene SCHEMBL28318053 | 0.90 | ATM (0.65) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL21366228 | 0.90 | ATM (0.65) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| SCHEMBL3715051 | 0.89 | ATM (0.69) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 | |
| Potassium Ion SCHEMBL4099103 | 0.88 | ATM (0.62) | ATMALDH1A1CYP2A6CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117344369-A | Method for preparing low-humidity water-absorbing aluminum-based MOF material monocrystal based on carboxylate hydrolysis | 浙江大学 | 2024-01-05 | — | — | CN | claimed |
| CN-1418627-A | Nitrophendipine oral disintegrant for treating angina pectoris, and its prepn. method | WANG DENGZHI (CN) | 2003-05-21 | — | — | CN | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| EP-0167371-B1 | DIHYDROPYRIDINE COMPOUNDS, THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1991-03-06 | — | — | EP | claimed |
| US-4968803-A | FLUORINE AS OXIDANT | ALLIED-SIGNAL INC. (US) | 1990-11-06 | — | — | US | claimed |
| CN-118879403-A | Preparation process based on butter nanometer degumming and neutralization technology | 广汉市迈德乐食品有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-20240327385-A1 | SUBSTITUTED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS | LIANG GUIBAI (US) | 2024-10-03 | — | — | US | disclosed |
| WO-2024153208-A9 | MACROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2024-08-22 | — | — | WO | disclosed |
| CN-118525020-A | Compound with CLK and DYRK inhibiting activity, preparation method and application thereof | 赛诺哈勃药业（成都）有限公司 | 2024-08-20 | — | — | CN | disclosed |
| WO-2024153208-A1 | MACROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2024-07-25 | — | — | WO | disclosed |
| US-20240156780-A1 | TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | AXIAL THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11951094-B2 | TLR2 modulator compounds, pharmaceutical compositions and uses thereof | AXIAL THERAPEUTICS, INC. (US) | 2024-04-09 | — | — | US | disclosed |
| EP-0052471-B1 | PROCESS AND CATALYST FOR POLYMERIZATION OF OLEFINS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-09-18 | — | — | EP | disclosed |
| US-4526941-A | Contacting alpha olefin with catalyst comprising organomagnesium compound, titanium compound, nitrogen or sulfur heterocyclic compound, slurry component and organometallic component | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-07-02 | — | — | US | disclosed |
| US-4525555-A | TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS | NIPPON OIL COMPANY, LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
| US-4428935-A | BETA-LACTAMASE INHIBITORS | PFIZER INC. (US) | 1984-01-31 | — | — | US | disclosed |
| EP-0095341-A1 | Penicillanic acid dioxide prodrug | PFIZER INC. (US) | 1983-11-30 | — | — | EP | disclosed |
| EP-0052471-A1 | Process and catalyst for polymerization of olefins | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4330650-A | HAVING MAGNESIUM COMPONENTS, TITANIUM COMPONENTS, ORGANOALUMINUM COMPONENTS AND HETEROCYCLIC CARBOXYLIC ESTER ELECTRON DONOR COMPONENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-05-18 | — | — | US | disclosed |
| US-4255280-A | ORGANOMAGNESIUM, CHLOROSILANE, TITANIUM, ORGANOMETALLIC AND HETEROCYCLIC ESTER COMPONENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327385-A1 | SUBSTITUTED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS | REN, ACE, AGTR1 | ATM 4743/4885ALDH1A1 523/4885CYP2A6 769/4885 |
| US-20240156780-A1 | TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | TLR2, TLR3, TLR4 | ATM 440/4885ALDH1A1 4063/4885CYP2A6 3780/4885 |
| US-11951094-B2 | TLR2 modulator compounds, pharmaceutical compositions and uses thereof | TLR2, TLR3, TLR4 | ATM 440/4885ALDH1A1 4063/4885CYP2A6 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.